Q3 2023 · 13F-HR
Casdin Capital, LLCholdings as filed
Filed 2023-11-14 · accession 0000919574-23-006405
$903.5M
Reported value
40
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $122.5M | 13.6% | 1,010,330 | Common | SOLE |
| 09062W204 | BLFS | BIOLIFE SOLUTIONS INC | $107.4M | 11.9% | 7,780,000 | Common | SOLE |
| 26886C107 | — | EQRX INC | $87.8M | 9.71% | 39,527,669 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $62.0M | 6.86% | 1,258,166 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $58.2M | 6.44% | 6,923,574 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $50.1M | 5.55% | 1,810,000 | Common | SOLE |
| 92539P101 | — | VERVE THERAPEUTICS INC | $39.2M | 4.34% | 2,954,710 | Common | SOLE |
| 45826J105 | NTLA | INTELLIA THERAPEUTICS INC | $37.3M | 4.12% | 1,178,075 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $35.4M | 3.92% | 200,000 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $31.3M | 3.47% | 459,450 | Common | SOLE |
| 83444K105 | SLGCUSD | SOMALOGIC INC | $30.1M | 3.33% | 12,604,275 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $27.3M | 3.03% | 1,577,108 | Common | SOLE |
| 24823R105 | DNLI | DENALI THERAPEUTICS INC | $26.8M | 2.97% | 1,300,000 | Common | SOLE |
| 60468T105 | MRTXEUR | MIRATI THERAPEUTICS INC | $21.7M | 2.40% | 498,427 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $18.7M | 2.06% | 371,378 | Common | SOLE |
| 87990A106 | TNYA | TENAYA THERAPEUTICS INC | $16.3M | 1.80% | 6,381,377 | Common | SOLE |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $14.7M | 1.63% | 1,307,349 | Common | SOLE |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $13.7M | 1.52% | 570,000 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $13.2M | 1.46% | 1,033,811 | Common | SOLE |
| 81663L200 | WGS | GENEDX HOLDINGS CORP | $11.3M | 1.25% | 3,095,511 | Common | SOLE |
| 00288U106 | ABCL | ABCELLERA BIOLOGICS INC | $10.9M | 1.20% | 2,360,129 | Common | SOLE |
| 69404D108 | PACB | PACIFIC BIOSCIENCES CALIF IN | $8.6M | 0.96% | 1,035,859 | Common | SOLE |
| 05370A108 | RNAGBP | AVIDITY BIOSCIENCES INC | $8.0M | 0.88% | 1,250,000 | Common | SOLE |
| 901384107 | TSVT* | 2SEVENTY BIO INC | $7.9M | 0.88% | 2,023,913 | Common | SOLE |
| 15673T100 | IPSC | CENTURY THERAPEUTICS INC | $6.4M | 0.71% | 3,206,380 | Common | SOLE |
| 57777K106 | MXCT | MAXCYTE INC | $5.9M | 0.65% | 1,890,000 | Common | SOLE |
| 31189P102 | FATE | FATE THERAPEUTICS INC | $4.3M | 0.48% | 2,050,000 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $3.5M | 0.39% | 20,000 | CALL | SOLE |
| 74168J101 | PRME | PRIME MEDICINE INC | $3.5M | 0.39% | 367,175 | Common | SOLE |
| 34385P108 | LAB | STANDARD BIOTOOLS INC | $3.5M | 0.39% | 1,200,000 | Common | SOLE |
| 452327109 | ILMN | ILLUMINA INC | $3.4M | 0.38% | 25,000 | Common | SOLE |
| 452327109 | ILMN | ILLUMINA INC | $3.4M | 0.38% | 25,000 | CALL | SOLE |
| 799566104 | SANA | SANA BIOTECHNOLOGY INC | $2.9M | 0.32% | 750,000 | Common | SOLE |
| 61225M102 | GLUE | MONTE ROSA THERAPEUTICS INC | $2.4M | 0.27% | 510,882 | Common | SOLE |
| 00091E109 | ABSI | ABSCI CORPORATION | $1.3M | 0.14% | 973,260 | Common | SOLE |
| 30223G102 | EXAIEUR | EXSCIENTIA PLC | $966,828 | 0.11% | 213,900 | Common | SOLE |
| 192005106 | CDXS | CODEXIS INC | $567,000 | 0.06% | 300,000 | Common | SOLE |
| 82933R100 | — | SINGULAR GENOMICS SYSTEMS IN | $504,400 | 0.06% | 1,323,885 | Common | SOLE |
| 53000N108 | LIANY | LIANBIO | $307,558 | 0.03% | 206,415 | Common | SOLE |
| 50107A104 | KRON1USD | KRONOS BIO INC | $160,991 | 0.02% | 123,839 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.